Search - tctmd.com

Displaying 161 - 180 of 606

Sort: Relevancy | Date

Presentation TCT 2017

Classifying Aortic Stenosis According to Pathophysiology and Hemodynamics An Echocardiographers Perspective

Presenter: Philippe Pibarot

October 30, 2017

Presentation TCT 2017

A Rare Complication of Valve-in-valve TAVR: Dynamic Intracavitary LV Obstruction

Presenter: Wojtek Wojakowski, Edwina C Wing-Lun

October 30, 2017

Presentation TCT 2017

How to Optimally Perform Valve-in-Valve Implantation in a Small Surgical Valve (Including Bioprosthetic Valve Fracture) Case Examples

Presenter: Danny Dvir

October 30, 2017

Presentation TCT 2017

A Case of TAVR, Left Main PCI and Permanent Pacemaker Implantation in a Nonagenarian

Presenter: Wojtek Wojakowski, Gautam Naik

October 30, 2017

Presentation TCT 2017

Important Clinical Lessons From the VIVID Registry and the PARTNER Experience

Presenter: John G. Webb

October 30, 2017

Presentation TCT 2017

Understanding Surgical Aortic Valve Anatomy: Implications for Valve-in-Valve Therapy

Presenter: Vinayak Bapat

October 30, 2017

Presentation TCT 2017

The NOTION 2 Low-risk Trial in Younger Patients

Presenter: Lars Sondergaard

October 30, 2017

Presentation TCT 2017

The Evolut R Low-risk Trial

Presenter: Jeffrey J. Popma

October 30, 2017

Presentation TCT 2017

Malposition of the Evolut R Bioprosthesis During TAVR

Presenter: Mohamed Ahmed Sobhy, Tomasz Gasior

October 30, 2017

Presentation TCT 2017

The PARTNER 3 Low-risk Trial

Presenter: Michael J. Mack

October 30, 2017

Presentation TCT 2017

The UK All-comer TAVI Study

Presenter: Neil E. Moat

October 30, 2017

Presentation TCT 2017

Impella and Rotablation-assisted Bifurcation PCI Following Previous Edwards SAPIEN 3 TAVR

Presenter: Mohamed Ahmed Sobhy, Faisal Khan

October 30, 2017

Presentation TCT 2017

Viewpoint #2: Not So Fast! GARY and Other Studies Indicate an Important Role for Surgery in Intermediate-risk Patients

Presenter: Thomas Walther

October 30, 2017

Presentation TCT 2017

Viewpoint #1: PARTNER 2A and SURTAVI are Convincing TAVR is Preferred in ALL (Appropriate) Intermediate-Risk Patients

Presenter: Michael J. Reardon

October 30, 2017

Presentation TCT 2017

Featured Lecture: Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis or Surgical Aortic Valve Replacement in Intermediate-Risk Patients : Complete 1-Year Outcomes from the SURTAVI Trial

Presenter: Martin B. Leon, Patrick T. O'Gara, Nicolas M. Van Mieghem

October 30, 2017

Presentation TCT 2017

Insights From the New 2017 ESC Valve Disease Guidelines: Changes in the Management of Aortic Stenosis

Presenter: Martin B. Leon, Patrick T. O'Gara, Olaf Wendler

October 30, 2017

Presentation TCT 2017

Take-home Messages for Managing Aortic Valve Disease From the 2017 AHA/ACC Focused Update

Presenter: Martin B. Leon, Patrick T. O'Gara, Allan Schwartz

October 30, 2017

Presentation TCT 2017

Futuristic and Novel #2: Using Artificial Intelligence (Machine Learning) to Direct Acquisition and Interpretation of Echocardiograms Improving Access and Quality of Valve Disease Diagnosis

Presenter: Robert O. Bonow, Michael J. Mack, Randolph P. Martin

October 30, 2017

Presentation TCT 2017

Futuristic and Novel #1: The Promise of Tissue Engineered Bioprosthetic Heart Valves (Both Surgical and Transcatheter) is Within Reach

Presenter: Robert O. Bonow, Michael J. Mack, Maximilian Y Emmert

October 30, 2017

Presentation TCT 2017

From Traditional Society Guidelines to Rapid Communications (e.g. BMJ WikiRecs): Evidence Development, Clinical Practice Standards, and Treatment Recommendations

Presenter: Robert O. Bonow, Michael J. Mack, David Hildick-Smith

October 30, 2017

Advertisement

Classifying Aortic Stenosis According to Pathophysiology and Hemodynamics An Echocardiographers Perspective

A Rare Complication of Valve-in-valve TAVR: Dynamic Intracavitary LV Obstruction

How to Optimally Perform Valve-in-Valve Implantation in a Small Surgical Valve (Including Bioprosthetic Valve Fracture) Case Examples

A Case of TAVR, Left Main PCI and Permanent Pacemaker Implantation in a Nonagenarian

Important Clinical Lessons From the VIVID Registry and the PARTNER Experience

Understanding Surgical Aortic Valve Anatomy: Implications for Valve-in-Valve Therapy

The NOTION 2 Low-risk Trial in Younger Patients

The Evolut R Low-risk Trial

Malposition of the Evolut R Bioprosthesis During TAVR

The PARTNER 3 Low-risk Trial

The UK All-comer TAVI Study

Impella and Rotablation-assisted Bifurcation PCI Following Previous Edwards SAPIEN 3 TAVR

Viewpoint #2: Not So Fast! GARY and Other Studies Indicate an Important Role for Surgery in Intermediate-risk Patients

Viewpoint #1: PARTNER 2A and SURTAVI are Convincing TAVR is Preferred in ALL (Appropriate) Intermediate-Risk Patients

Featured Lecture: Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis or Surgical Aortic Valve Replacement in Intermediate-Risk Patients : Complete 1-Year Outcomes from the SURTAVI Trial

Insights From the New 2017 ESC Valve Disease Guidelines: Changes in the Management of Aortic Stenosis

Take-home Messages for Managing Aortic Valve Disease From the 2017 AHA/ACC Focused Update

Futuristic and Novel #2: Using Artificial Intelligence (Machine Learning) to Direct Acquisition and Interpretation of Echocardiograms Improving Access and Quality of Valve Disease Diagnosis

Futuristic and Novel #1: The Promise of Tissue Engineered Bioprosthetic Heart Valves (Both Surgical and Transcatheter) is Within Reach

From Traditional Society Guidelines to Rapid Communications (e.g. BMJ WikiRecs): Evidence Development, Clinical Practice Standards, and Treatment Recommendations

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content